Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Oct 15, 2011 (Vol. 31, No. 18)

International Aging Research Portfolio (IARP)

URL:www.agingportfolio.org
  • Nice design, many ways to explore site
  • Nothing significant

I never grow tired of exploring fantastically designed websites, and with the International Aging Research Portfolio I was not disappointed. The IARP is an independent nonprofit initiative that brings together resources for the many parties involved in aging research including charities, academic and corporate researchers, and patient advocacy groups. Besides simply having a beautifully manicured website, the IARP provides a large amount of information related to the funding of aging research. This information is perhaps most easily browsed via the “Search Projects” field on the homepage, wherein 102 (yes, that’s right!) different topics are indexed to allow users to literally search anything from A–Z (or rather, from “accumulative-waste theory” to “zinc metabolism”). Alternatively, visitors to the site can explore sections such as funding organizations and sources, commercial applications and companies, and biotechnology video casts and training. No matter how you decide to browse the site, you will find plenty of useful information.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »